Prospective Longitudinal Cohort Study of Vasculitis Patients

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jun 1, 2020

Keywords

ClinConnect Summary

The VASCO study is a research project that aims to learn more about patients with vasculitis, which is a condition where the body's immune system mistakenly attacks its own blood vessels. This study will follow patients over time to gather information about how the disease shows up, other health issues they might have, how they are treated, and the long-term effects of the disease. The goal is to improve care for people living with vasculitis.

To participate in this study, you need to be an adult over 18 years old and currently experiencing an active phase of vasculitis, either as a first-time flare-up or a relapse. If you are pregnant or breastfeeding, you can still join. Participants will be asked to give their consent and share information about their health. The study is currently recruiting new patients, and it aims to provide valuable insights that could lead to better treatment options in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (age over 18 years),
• • Patients with vasculitis, as defined in the Chapel Hill International Nomenclature as revised in 2012,
• • Patients included at an active phase of the disease, either the initial flare or a relapse,
• • Patients who have been informed and have signed the consent
• • Pregnant and breastfeeding women may be included in the study,
• • Affiliated to a social security system (beneficiary or entitled person).
• Exclusion Criteria:
• • Refusal of consent or inability to obtain consent,
• • A patient who is insane or not entitled, for psychiatric reasons or intellectual impairment, to receive information about the protocol and to give informed consent,
• • Patient under guardianship / curators
• • Patient on state medical assistance (AME)
• • Hemoglobin less than 7 g/dl at the time of sampling,
• • Hemoglobin level less than 9 g/dl at the time of sampling if the patient has respiratory or cardiovascular disease,
• • Patient weighs less than 18 kg.
• • Parallel participation in an interventional protocol is permitted.